Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platinum-based chemotherapy for bladder cancer

J Waxman1, H Wasan

  • 1Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Seminars in Oncology
|October 1, 1994
PubMed
Summary

Surgery and radiotherapy often fail to cure advanced urothelial cancer. This review examines radiation and surgical outcomes, contextualizing chemotherapy advancements for this malignancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Oncogene·2026
Same author

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022.

ESMO open·2023
Same author

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC.

ESMO open·2022
Same author

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

British journal of cancer·2022
Same author

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study.

ESMO open·2021

Area of Science:

  • Oncology
  • Urologic Oncology

Background:

  • Advanced urothelial cancer presents a significant clinical challenge.
  • Current treatments like surgery and radiotherapy have limitations in achieving cures.

Purpose of the Study:

  • To review the efficacy of radiation and surgery for advanced urothelial cancer.
  • To contextualize recent chemotherapy advancements within existing treatment paradigms.

Main Methods:

  • Literature review of surgical and radiation therapy outcomes.
  • Analysis of chemotherapy advancements in urothelial cancer treatment.

Main Results:

  • Surgery and radiotherapy alone have limited success rates in curing advanced urothelial cancer.
  • Chemotherapy has emerged as a critical component in managing this disease.

Conclusions:

  • There is a need for improved therapeutic strategies for advanced urothelial cancer.
  • Chemotherapy offers promising advancements in improving outcomes for patients with urothelial cancer.

Related Experiment Videos